Annual Total Long Term Liabilities
$1.74 M
-$8.08 M-82.31%
December 31, 2023
Summary
- As of February 7, 2025, RDHL annual total long term liabilities is $1.74 million, with the most recent change of -$8.08 million (-82.31%) on December 31, 2023.
- During the last 3 years, RDHL annual total long term liabilities has fallen by -$91.41 million (-98.14%).
- RDHL annual total long term liabilities is now -98.14% below its all-time high of $93.14 million, reached on December 31, 2020.
Performance
RDHL Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$730.00 K
-$2.65 M-78.40%
June 1, 2024
Summary
- As of February 7, 2025, RDHL quarterly total long term liabilities is $730.00 thousand, with the most recent change of -$2.65 million (-78.40%) on June 1, 2024.
- Over the past year, RDHL quarterly long term liabilities has dropped by -$2.65 million (-78.40%).
- RDHL quarterly long term liabilities is now -99.33% below its all-time high of $108.58 million, reached on September 30, 2020.
Performance
RDHL Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
RDHL Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -82.3% | -78.4% |
3 y3 years | -98.1% | -78.4% |
5 y5 years | +105.7% | -78.4% |
RDHL Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -98.1% | at low | -99.3% | at low |
5 y | 5-year | -98.1% | at low | -99.3% | at low |
alltime | all time | -98.1% | -100.0% | -99.3% | -100.0% |
RedHill Biopharma Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2024 | - | $730.00 K(-78.4%) |
Dec 2023 | $1.74 M(-82.3%) | - |
Jun 2023 | - | $3.38 M(-59.7%) |
Mar 2023 | - | $8.39 M(-14.5%) |
Dec 2022 | $9.82 M(-89.2%) | $9.82 M(+1.3%) |
Sep 2022 | - | $9.69 M(-28.2%) |
Jun 2022 | - | $13.49 M(-86.3%) |
Mar 2022 | - | $98.39 M(+8.3%) |
Dec 2021 | $90.84 M(-2.5%) | $90.84 M(-2.5%) |
Sep 2021 | - | $93.13 M(-1.9%) |
Jun 2021 | - | $94.92 M(-5.5%) |
Mar 2021 | - | $100.45 M(+7.8%) |
Dec 2020 | $93.14 M(+2575.7%) | $93.14 M(-14.2%) |
Sep 2020 | - | $108.58 M(+13.2%) |
Jun 2020 | - | $95.91 M(+16.2%) |
Mar 2020 | - | $82.51 M(+2270.2%) |
Dec 2019 | $3.48 M(+312.4%) | $3.48 M(-0.9%) |
Sep 2019 | - | $3.51 M(-6.0%) |
Jun 2019 | - | $3.74 M(-10.4%) |
Mar 2019 | - | $4.17 M(+394.2%) |
Dec 2018 | $844.00 K | $844.00 K(-66.7%) |
Sep 2018 | - | $2.54 M(+22.8%) |
Jun 2018 | - | $2.06 M(+418.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2018 | - | $398.00 K(-11.2%) |
Dec 2017 | $448.00 K(-92.7%) | $448.00 K(-89.6%) |
Sep 2017 | - | $4.31 M(+64.3%) |
Jun 2017 | - | $2.62 M(-46.2%) |
Mar 2017 | - | $4.87 M(-20.8%) |
Dec 2016 | $6.16 M(+397.6%) | $6.16 M(+456.0%) |
Sep 2016 | - | $1.11 M(+112.1%) |
Jun 2016 | - | $522.00 K(-49.6%) |
Mar 2016 | - | $1.04 M(-16.2%) |
Dec 2015 | $1.24 M(-41.8%) | $1.24 M(-11.8%) |
Sep 2015 | - | $1.40 M(-48.9%) |
Jun 2015 | - | $2.75 M(+46.3%) |
Mar 2015 | - | $1.88 M(-11.7%) |
Dec 2014 | $2.13 M(>+9900.0%) | $2.13 M(+20.3%) |
Sep 2014 | - | $1.77 M(-38.2%) |
Jun 2014 | - | $2.86 M(+23.8%) |
Mar 2014 | - | $2.31 M(>+9900.0%) |
Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2013 | - | $0.00(0.0%) |
Jun 2013 | - | $0.00(0.0%) |
Mar 2013 | - | $0.00(0.0%) |
Dec 2012 | $0.00(-100.0%) | $0.00(-100.0%) |
Sep 2012 | - | $1.01 M(+14.6%) |
Dec 2011 | $886.00 K | $886.00 K |
FAQ
- What is RedHill Biopharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for RedHill Biopharma?
- What is RedHill Biopharma annual total long term liabilities year-on-year change?
- What is RedHill Biopharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for RedHill Biopharma?
- What is RedHill Biopharma quarterly long term liabilities year-on-year change?
What is RedHill Biopharma annual total long term liabilities?
The current annual total long term liabilities of RDHL is $1.74 M
What is the all time high annual total long term liabilities for RedHill Biopharma?
RedHill Biopharma all-time high annual total long term liabilities is $93.14 M
What is RedHill Biopharma annual total long term liabilities year-on-year change?
Over the past year, RDHL annual total long term liabilities has changed by -$8.08 M (-82.31%)
What is RedHill Biopharma quarterly total long term liabilities?
The current quarterly long term liabilities of RDHL is $730.00 K
What is the all time high quarterly long term liabilities for RedHill Biopharma?
RedHill Biopharma all-time high quarterly total long term liabilities is $108.58 M
What is RedHill Biopharma quarterly long term liabilities year-on-year change?
Over the past year, RDHL quarterly total long term liabilities has changed by -$2.65 M (-78.40%)